| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 01/19/2005 | CN1565647A Manufacturing method of tissue engineered cartilage |
| 01/19/2005 | CN1565644A Manufacturing method of tissue engineered bone |
| 01/19/2005 | CN1565643A Tissue engineered cartilage based on bone marrow mesenchymal stem cell |
| 01/19/2005 | CN1565627A Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 01/19/2005 | CN1565514A Chondriomere quality improving medicine and its preparing process and application |
| 01/19/2005 | CN1565168A Improved porphyra haitanensis variety selection and cultivation method |
| 01/19/2005 | CN1185348C Chimeric interleukin-6 soluble receptor/ligand protein and application thereof |
| 01/19/2005 | CN1185344C Protein for blocking platelet adhesion |
| 01/19/2005 | CN1185343C New growth-differentiation factor of the TGF-beta family |
| 01/19/2005 | CN1185339C Preparation of cells for producing biological products |
| 01/19/2005 | CN1185019C Dermal scaffold comprising nutralized chitosan sponge, nutralized chitosan/collagen mixed sponge |
| 01/19/2005 | CN1184961C Use of EGF-R antagonists in preparing drug |
| 01/18/2005 | US6844422 Inhibitor protein of the wnt signal pathway |
| 01/18/2005 | US6844327 Gene therapy approaches to supply apolipoprotein A-I agonists and their use to treat dyslipidemic disorders |
| 01/18/2005 | US6844312 Production of tyrosine hydroxylase positive neurons |
| 01/18/2005 | US6844192 Preparing preferential viral vectors; provide packaging cell, transfect with nucleotide sequences coding viral vector, culture transfected cells, recover packaged vector |
| 01/18/2005 | US6844191 Osteogenic cell growth using a TGFβ1-von Willebrand's factor fusion protein |
| 01/18/2005 | US6844189 Chromosome 17P-linked prostate cancer susceptibility gene |
| 01/18/2005 | US6844186 Disposable vessel |
| 01/18/2005 | US6844180 Nucleotide sequences for use in the treatment of viral diseases, hypertension and coagulation defects |
| 01/18/2005 | US6844175 Methods of inhibition using glycosyl sulfotransferase-3 |
| 01/18/2005 | US6844164 Antibody against rat postacrosome reaction sperm and utilization thereof |
| 01/18/2005 | US6844011 Methods for inhibiting rejection of transplanted tissue |
| 01/18/2005 | US6843999 Streptococcal ABC transporter protein |
| 01/18/2005 | US6843992 Immuno-reactive peptide CTL epitopes of human cytomegalovirus |
| 01/18/2005 | US6843989 Administering a CD40 binding protein that potentiates the binding of CD40 to CD40 ligand |
| 01/18/2005 | CA2251889C Process for producing and multiplying lymphocytes |
| 01/18/2005 | CA2144043C Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 01/13/2005 | WO2005003720A2 Method of detecting the cystic fibrosis transmembrane conductance regulator (cftr) at cell exterior |
| 01/13/2005 | WO2005003359A1 Method and system of constructing transgenic organism |
| 01/13/2005 | WO2005003342A1 Method of preparing transgenic organism with use of methylation and system therefor |
| 01/13/2005 | WO2005003335A2 Rapamycin resistant t cells and therapeutic uses thereof |
| 01/13/2005 | WO2005003334A2 Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
| 01/13/2005 | WO2005003333A2 Use of umbilical cord blood stem cells for preventing brain damage due to lack of oxygen and providing neuroprotection |
| 01/13/2005 | WO2005003332A2 Diamagnetically stabilised three-dimensional cell culture |
| 01/13/2005 | WO2005003331A1 Method of storing and/or transporting in vitro cell cultures |
| 01/13/2005 | WO2005003321A2 Methods of producing differentiated hematopoietic cells for treatment of cytopenia |
| 01/13/2005 | WO2005003320A2 Neuronal differentiation of stem cells |
| 01/13/2005 | WO2005003317A2 Engineered blood vessels |
| 01/13/2005 | WO2005003300A2 Tissue scaffold having aligned fibrils, apparatus and method for producing same, and methods of using same |
| 01/13/2005 | WO2005003297A2 Mptens as modifiers of the pten/igf pathway and methods of use |
| 01/13/2005 | WO2005003295A2 Methods and compositions for maturing dendritic cells utilizing inosine-containing compounds |
| 01/13/2005 | WO2005003287A1 Methods of cell culture |
| 01/13/2005 | WO2005003286A1 Culture control apparatus for cell or tissue and method thereof |
| 01/13/2005 | WO2005003172A2 Pan-kir2dl nk-receptor antibodies and their use in diagnostik and therapy |
| 01/13/2005 | WO2005003168A2 Methods for the production and cytotoxicity evaluation of kir2dl nk-receptor antibodies |
| 01/13/2005 | WO2005002643A2 Method and products for delivering biological molecules to cells using multicomponent nanostructures |
| 01/13/2005 | WO2005002628A1 Increased t-cell tumor infiltration by mutant light |
| 01/13/2005 | WO2005002601A1 Conditioned matrix compositions for tissue restoration |
| 01/13/2005 | WO2005002527A2 Sirt1 modulation of adipogenesis and adipose function |
| 01/13/2005 | WO2005002513A2 C1q complement inhibitors and methods of use thereof |
| 01/13/2005 | WO2005002511A2 Recombinant antibodies and compositions and methods for making and using the same |
| 01/13/2005 | WO2005002509A2 Dna vectors |
| 01/13/2005 | WO2005002499A2 A method and therapeutic platelets |
| 01/13/2005 | WO2005002326A2 Generation of plants with improved drought tolerance |
| 01/13/2005 | WO2004069876A3 Trimeric polypeptide construct to induce an enduring t cell response |
| 01/13/2005 | WO2004069191A3 Identification of t1r and t2r modulators |
| 01/13/2005 | WO2004027381A3 Methods and compositions related to inhibiting nuclear envelope breakdown |
| 01/13/2005 | WO2004000213A9 Method for growing human organs, treating diseases, and increasing longevity |
| 01/13/2005 | WO2003106645A3 Antisense modulation of smrt expression |
| 01/13/2005 | WO2003074073A3 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof |
| 01/13/2005 | WO2003072715A8 Gasp1: a follistatin domain containing protein |
| 01/13/2005 | US20050010974 Promoters for regulation of gene expression in plant roots |
| 01/13/2005 | US20050010966 Using nuclear transplantion of somatic cell genome to transform and generate cloned non-human mammal; bioengineering; tissue engineering |
| 01/13/2005 | US20050010965 Method for producing tissue engineered meat for consumption |
| 01/13/2005 | US20050010042 Expression vector comprising nucleotide sequences comprising pro-polypeptide for use in the diagnosis, prevention and treatment of cell proliferative, inflammatory, cardiovascuar and nervous system disorders |
| 01/13/2005 | US20050010035 Spider silk protein encoding nucleic acids, polypeptides, antibodies and methods of use thereof |
| 01/13/2005 | US20050009868 Mixture of one or more RAR pan-antagonist compounds each of which has a high binding affinity to RAR alpha , RAR beta and RAR gamma; is administered to a population of cells to inhibit RAR mediated signalling and/or enhance RAR mediated repression leading to increased chondrogenesis. |
| 01/13/2005 | US20050009187 Environmental stress-responsive promoter and genes encoding transcriptional factor |
| 01/13/2005 | US20050009186 Expression vector comprising 3' and 5' long terminal repeats and preferential splice junctions for use as heterologous gene transfer tool; gene therapy |
| 01/13/2005 | US20050009183 Antisense modulation of hypothetical protein LOC51249 expression |
| 01/13/2005 | US20050009182 Using recombinase to mediate irreversible site-specific polynucleotide replacement in eukaryotic cells; heterologous gene expression and tissue engineering |
| 01/13/2005 | US20050009181 Contacting bone marrow stromal cells with neuronal and/or endodermal precursor tissue, transfecting diffferentiated endoderm/neuronal tissues with vector comprising therapeutic protein for use in treatment of cancer, diabetes, pancreatitis, liver and inflammatory bowel diseases |
| 01/13/2005 | US20050009180 Method for the generation of antigen-specific lymphocytes |
| 01/13/2005 | US20050009179 Bioreactor and methods for tissue growth and conditioning |
| 01/13/2005 | US20050009178 Matrix comprised of biopolymer fibers for use in propagation and culturing of tissues; tissue engineering and regenerative medicine; tissue grafting; prosthetics |
| 01/13/2005 | US20050009176 Calcium phosphate cements prepared from silicate solutions |
| 01/13/2005 | US20050009167 Alkaline protease from Bacillus sp. (DSM 14390) and washing and cleaning products comprising said alkaline protease |
| 01/13/2005 | US20050009162 3-phosphoglycerate dehydrogenase variants whose inhibition by L-serine is reduced, and genes encoding them |
| 01/13/2005 | US20050009161 Enhancement of in vitro culture or vaccine production using electromagnetic energy treatment |
| 01/13/2005 | US20050009150 Humanized antibodies that recognize beta amyloid peptide |
| 01/13/2005 | US20050009147 Parathyroid hormone variants; site-directed mutagenesis; for treatment of bone disorders |
| 01/13/2005 | US20050009145 Mammalian receptor proteins; related reagents and methods |
| 01/13/2005 | US20050009144 Transgenic cell comprising nucleotide sequences coding endostatins for use as tool in identifying modulators for treatment and prevention of cell proliferative and angiogenesis-related disorders |
| 01/13/2005 | US20050009141 Epidermal differentiation factor |
| 01/13/2005 | US20050009140 Elongase genes and uses thereof |
| 01/13/2005 | US20050009139 Compositions and methods for generating chimeric heteromultimers |
| 01/13/2005 | US20050009137 Intracellular estradiol binding protein, a polynucleotide encoding the same and cell lines overexpressing the same |
| 01/13/2005 | US20050009114 Identification and quantification of organ-specific proteins derived from human allogeneic cells using proteomics |
| 01/13/2005 | US20050009085 44 Human secreted proteins |
| 01/13/2005 | US20050009084 Detection of polymorphisms in the human 5-lipoxygenase gene |
| 01/13/2005 | US20050009063 Compositions and methods for the release of nucleic acid molecules from solid matrices |
| 01/13/2005 | US20050009062 Phosphodiesterase 10 |
| 01/13/2005 | US20050009061 Anther-specific genes, their promoters, and uses of the same |
| 01/13/2005 | US20050009056 Anti-infective therapy |
| 01/13/2005 | US20050009025 A soluble T cell receptor for use as diagnostic indicator of infection and autoimmune diseases |
| 01/13/2005 | US20050009021 Isolated nucleic acid comprising polynucleotide of given sequence; diagnostic kits; use in treatment of cancer |
| 01/13/2005 | US20050009013 Preparing transfer RNA-coumarin marker conjugates for non-radioactive detection and analysis of translation |
| 01/13/2005 | US20050008708 Forming, preservation modelable biopolymer; harvesting tissue, deactivation of infections; applying pressure; tissue engineering |
| 01/13/2005 | US20050008651 Modulating replication via immunogen and pharmaceutically or veterinarily acceptable vehicles |